Detalhe da pesquisa
1.
Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer.
Int J Mol Sci
; 24(7)2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37047727
2.
Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer.
Acta Oncol
; 59(12): 1416-1423, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32790589
3.
MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.
BMC Cancer
; 15: 1024, 2015 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26714641
4.
The fibroblast hormone endotrophin is a biomarker of mortality in chronic diseases.
Matrix Biol
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38871093
5.
Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer.
Acta Oncol
; 51(2): 231-3, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21936753
6.
COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096534
7.
Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer.
Cancers (Basel)
; 13(15)2021 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359796
8.
Characteristics and early outcomes of patients hospitalised for COVID-19 in North Zealand, Denmark.
Dan Med J
; 67(9)2020 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32800073